Chimeric Antigen Receptor (CAR) T Cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2017
DelveInsight's Report, "Chimeric Antigen Receptor (CAR) T-cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2017" emphasizes on the currently active CAR-T cell products in research and development.
View full press release